Selecting and Utilizing Anti-BCMA Therapy in Relapsed and Refractory Multiple Myeloma Targeted Oncology 3:20 4 years ago 77 Далее Скачать
Anti-BCMA Therapy for Relapsed and Refractory Multiple Myeloma Targeted Oncology 3:32 4 years ago 177 Далее Скачать
Types of BCMA-Directed Therapies in Relapsed and Refractory Multiple Myeloma Targeted Oncology 8:31 4 years ago 109 Далее Скачать
Current and Future Directions for Novel Therapy for Multiple Myeloma: Paul G. Richardson, MD Dana-Farber Cancer Institute 37:46 2 years ago 1 952 Далее Скачать
Relapsed Therapy and Clinical Trials - RCW Pacific NW International Myeloma Foundation 41:02 3 years ago 317 Далее Скачать
Relapsed Refractory Multiple Myeloma | Current Treatment Options | Options on the Horizon Multiple Myeloma Research Foundation - MMRF 51:36 2 years ago 4 934 Далее Скачать
Ide-cel (formerly bb2121) anti-BCMA CAR T-cell therapy in relapsed/refractory MM VJHemOnc – Video Journal of Hematology & HemOnc 1:56 7 years ago 270 Далее Скачать
Anti-BCMA Bispecific Antibody for Myeloma Relapse After CAR T Cells International Academy for Clinical Hematology IACH 44:36 1 year ago 234 Далее Скачать
Meta-analysis: anti-BCMA CAR-T in R/R multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 5:00 4 years ago 102 Далее Скачать
Alnuctamab, a BCMA x CD3 T-Cell Engager, in Pts with Relapsed/Refractory Multiple Myeloma International Myeloma Foundation 8:36 1 year ago 569 Далее Скачать
Efficacy and Safety of P-Bcma-101 CAR-T Cells in Patients with Relapsed/Refractory Multiple Myeloma International Myeloma Foundation 4:25 5 years ago 245 Далее Скачать
BCMA-directed therapies for the treatment of relapsed/refractory multiple myeloma Xpeer Medical Education 1:43 9 months ago 31 Далее Скачать
Using BCMA-targeting agents in earlier lines of treatment for multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 1:38 2 years ago 108 Далее Скачать
Optimising the management of multiple myeloma in the early relapsed/refractory setting COR2ED The Heart of Medical Education 1:16:23 5 months ago 29 157 Далее Скачать
Teclistamab in relapsed/refractory multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 3:17 3 years ago 300 Далее Скачать
Efficacy and safety of elranatamab BCMA-CD3 bispecific antibody, in patients with RRMM International Myeloma Foundation 7:06 3 years ago 1 088 Далее Скачать
bb21217: next gen anti-BCMA CAR-T for R/R MM VJHemOnc – Video Journal of Hematology & HemOnc 2:28 4 years ago 91 Далее Скачать
Biallelic Loss of BCMA Triggers Resistance to Anti-BCMA CAR T Cell Therapy in Multiple Myeloma International Myeloma Foundation 9:38 3 years ago 433 Далее Скачать
